Clinical Trial Update: Efficacy and Tolerance of Naked DNA Vaccine in Patients With Chronic B Hepatitis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial assessed the efficacy and tolerability of a naked DNA vaccine in patients with chronic hepatitis B; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Naked DNA Vaccine

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: Chronic Hepatitis B | Phase 1, Phase 2 | Status: COMPLETED